Evidence map›Paper›PMID 30643026›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2019

Grey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in Adolescence.

Catherine Orr, Philip Spechler, Zhipeng Cao, Matthew Albaugh, Bader Chaarani, Scott Mackey, Deepak D'Souza, Nicholas Allgaier, Tobias Banaschewski, Arun L W Bokde and 25 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 4 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 4 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 17 institutions in 9 countries.

Catherine OrrDepartments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05405, corr@swin.edu.au.
Philip SpechlerDepartments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05405.
Zhipeng CaoDepartment of Psychology, University College Dublin, Dublin 4, Ireland.
Matthew AlbaughDepartments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05405.
Bader ChaaraniDepartments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05405.
Scott MackeyDepartments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05405.
Deepak D'SouzaDepartment of Psychiatry, Yale University School of Medicine, West Haven, Connecticut 06516.
Nicholas AllgaierDepartments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05405.ORCID 0000-0002-9498-0200
Tobias BanaschewskiDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
Arun L W BokdeDiscipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin 2, Ireland.ORCID 0000-0003-0114-4914
Uli BrombergUniversity Medical Centre Hamburg-Eppendorf, 20246, Hamburg, Germany.
Christian BüchelUniversity Medical Centre Hamburg-Eppendorf, 20246, Hamburg, Germany.
Erin Burke QuinlanCentre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, WC2R 2LS United Kingdom.
Patricia ConrodCentre de recherche du CHU Ste-Justine and.
Sylvane DesrivièresCentre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, WC2R 2LS United Kingdom.
Herta FlorDepartment of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.ORCID 0000-0003-4809-5398
Vincent FrouinNeuroSpin, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France.
Penny GowlandSir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, NG7 2RD United Kingdom.ORCID 0000-0002-4900-4817
Andreas HeinzDepartment of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, 10117 Berlin, Germany.
Bernd IttermannPhysikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany, Berlin, 10587 Germany.
Jean-Luc MartinotInstitut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging and Psychiatry", University Paris Sud-University Paris Saclay, DIGITEO Labs, 91190 Gif sur Yvette, France.
Marie-Laure Paillère MartinotInstitut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging and Psychiatry", and AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, 75014 Paris, France.
Frauke NeesDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
Dimitri Papadopoulos OrfanosNeuroSpin, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France.ORCID 0000-0002-1242-8990
Tomáš PausRotman Research Institute, Baycrest, and Departments of Psychology and Psychiatry, University of Toronto, Toronto, Ontario M6A 2E1, Canada.
Luise PoustkaDepartment of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, 37075, Göttingen, Germany.
Sabina MillenetDepartment of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
Juliane H FröhnerDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, 01069 Germany.
Rajiv RadhakrishnanDepartment of Psychiatry, Yale University School of Medicine, West Haven, Connecticut 06516.
Michael N SmolkaDepartment of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, 01069 Germany.
Henrik WalterDepartment of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, 10117 Berlin, Germany.
Robert WhelanDepartment of Psychology, University College Dublin, Dublin 4, Ireland.ORCID 0000-0002-2790-7281
Gunter SchumannCentre for Population Neuroscience and Stratified Medicine (PONS) and MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, WC2R 2LS United Kingdom.
Alexandra PotterDepartments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05405.
Hugh GaravanDepartments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05405.
University of Vermont · USHeidelberg University · DEKing's College London · GBCharité - Universitätsmedizin Berlin · DECommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRInserm · FRTechnische Universität Dresden · DEUniversität Hamburg · DEUniversity College Dublin · IEYale University · USHEC Montréal · CAMedical University of Vienna · ATPhysikalisch-Technische Bundesanstalt · DETrinity College Dublin · IEUniversity of Mannheim · DEUniversity of Nottingham · GBUniversity of Toronto · CA

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
Axon, Testosterone and Mental Health during AdolescenceR01MH085772 · NIMH · BAYCREST CENTRE FOR GERIATRIC CARE · PI PAUS, TOMAS · 2010 to 2014
$1.5M
Medical Research Council MR/N027558/1NCATS NIH HHS UL1 TR001863NIBIB NIH HHS U54 EB020403NIMH NIH HHS R01 MH085772
6 · The paper itself

Abstract

Rates of cannabis use among adolescents are high, and are increasing concurrent with changes in the legal status of marijuana and societal attitudes regarding its use. Recreational cannabis use is understudied, especially in the adolescent period when neural maturation may make users particularly vulnerable to the effects of Δ-9-tetrahydrocannabinol (THC) on brain structure. In the current study, we used voxel-based morphometry to compare gray matter volume (GMV) in forty-six 14-year-old human adolescents (males and females) with just one or two instances of cannabis use and carefully matched THC-naive controls. We identified extensive regions in the bilateral medial temporal lobes as well as the bilateral posterior cingulate, lingual gyri, and cerebellum that showed greater GMV in the cannabis users. Analysis of longitudinal data confirmed that GMV differences were unlikely to precede cannabis use. GMV in the temporal regions was associated with contemporaneous performance on the Perceptual Reasoning Index and with future generalized anxiety symptoms in the cannabis users. The distribution of GMV effects mapped onto biomarkers of the endogenous cannabinoid system providing insight into possible mechanisms for these effects.

Indexed as

AdolescentBrainCerebellumFemaleGray MatterGyrus CinguliHumansMaleMarijuana SmokingTemporal Lobeadolescent substance usecannabiscognitionmarijuanapsychopathologyvoxel-based morphometry

Identifiers

PMID30643026
PMCPMC6407302
OpenAlexW2911110882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.